Table 2a.
Prevalence of Cardiovascular/Metabolic Conditions among New York City Adults in Care, Past Year (2013)
| OUTCOME | # PRACTICES RESPONDING TO AUTOQUERY | 2013 | 2013–2014 | STATISTICALLY | |
|---|---|---|---|---|---|
|
|
|
|
|||
| NYC MACROSCOPEa | NYC HANES | EQUIVALENT | DIFFERENT | ||
|
|
|
|
|||
| % (95% Cl) | % (95% Cl) | (TOSTb) | (T TEST) | ||
| HYPERTENSION PREVALENCE DEFINITIONS | |||||
| Base - Diagnosis only | 380 | 32.3 (32.2–32.4) | 32.5 (29.4–35.7) | 0.001 | 0.93 |
|
| |||||
| Augmented - Diagnosis, meds, or condition indicated during BP measurement | 357 | 39.2 (39.1–39.3) | 40.3 (37.3–43.5) | 0.007 | 0.47 |
|
| |||||
| Survey Gold Standard - Diagnosis and on HTN meds, or HTN indicated during BP exam | 360 | 33.7 (33.6–33.8) | 35.5 (32.5–38.7) | 0.02 | 0.25 |
| HYPERLIPIDEMIA PREVALENCE DEFINITIONS | |||||
| Base - Diagnosis only | 388 | 49.3 (49.1–49.5) | 46.9 (42.6–51.3) | 0.12 | 0.29 |
|
| |||||
| Augmented - Diagnosis, meds, or condition indicated in labs | 330 | 54.5 (54.4–54.7) | 56.8 (52.3–61.2) | 0.11 | 0.31 |
|
| |||||
| Survey Gold Standard - Diagnosis and on CHOL meds, or condition indicated in labs | 295 | 34.0 (33.8–34.2) | 41.0 (36.7–45.4) | 0.81 | 0.002 |
| DIABETES PREVALENCE DEFINITIONS | |||||
| Base - Diagnosis only | 383 | 13.9 (13.8–14.0) | 12.6 (10.6–14.8) | <0.001 | 0.19 |
|
| |||||
| Augmented - Diagnosis, meds, or condition indicated in labs | 330 | 15.3 (15.2–15.3) | 17.8 (15.5–20.4) | 0.03 | 0.04 |